Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
mild (no stridor at rest)
corticosteroid + supportive care
A single dose of oral dexamethasone is given as soon as the clinical diagnosis of croup has been made. Its effect in reducing the clinical signs of croup is seen within 2 hours, with further beneficial effects noted up to 10 hours following administration.[38]Johnson DW, Jacobson S, Edney PC, et al. A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. N Engl J Med. 1998 Aug 20;339(8):498-503. http://www.ncbi.nlm.nih.gov/pubmed/9709042?tool=bestpractice.com
Traditionally, a dose of 0.6 mg/kg/dose was used for croup; however, evidence now supports the use of a smaller dose of 0.15 mg/kg/dose.[59]Aregbesola A, Tam CM, Kothari A, et al. Glucocorticoids for croup in children. Cochrane Database Syst Rev. 2023 Jan 10;1(1):CD001955. https://www.doi.org/10.1002/14651858.CD001955.pub5 http://www.ncbi.nlm.nih.gov/pubmed/36626194?tool=bestpractice.com
Care should be taken to avoid frightening the child, as agitation may cause worsening of symptoms.[19]Johnson D, Klassen T, Kellner J. Diagnosis and management of croup: Alberta Medical Association clinical practice guidelines. Alberta: Alberta Medical Association; 2015 [internet publication]. https://www.topalbertadoctors.org/cpgs.php?sid=12&cpg_cats=35 Especially in mild croup, parental assurance and education to the self-limited nature of the illness is important.
Historically mist or humidified air have been widely employed, but there is now convincing evidence that these are ineffective[19]Johnson D, Klassen T, Kellner J. Diagnosis and management of croup: Alberta Medical Association clinical practice guidelines. Alberta: Alberta Medical Association; 2015 [internet publication]. https://www.topalbertadoctors.org/cpgs.php?sid=12&cpg_cats=35 [85]Henry R. Moist air in the treatment of laryngotracheitis. Arch Dis Child. 1983 Aug;58(8):577. https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=6614970 http://www.ncbi.nlm.nih.gov/pubmed/6614970?tool=bestpractice.com [86]Lenney W, Milner AD. Treatment of acute viral croup. Arch Dis Child. 1978 Sep;53(9):704-6. https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=718237 http://www.ncbi.nlm.nih.gov/pubmed/718237?tool=bestpractice.com [87]Bourchier D, Dawson KP, Fergusson DM. Humidification in viral croup: a controlled trial. Aust Paediatr J. 1984 Nov;20(4):289-91. http://www.ncbi.nlm.nih.gov/pubmed/6397182?tool=bestpractice.com [88]Skolnik N. Treatment of croup. A critical review. Am J Dis Child. 1989 Sep;143(9):1045-9. http://www.ncbi.nlm.nih.gov/pubmed/2672782?tool=bestpractice.com [89]Neto GM, Kentab O, Klassen TP, et al. A randomized controlled trial of mist in the acute treatment of moderate croup. Acad Emerg Med. 2002 Sep;9(9):873-9. http://www.ncbi.nlm.nih.gov/pubmed/12208675?tool=bestpractice.com [90]Lavine E, Scolnik D. Lack of efficacy of humidification in the treatment of croup. Why do physicians persist in using an unproven modality? CJEM. 2001 Jul;3(3):209-12. http://www.ncbi.nlm.nih.gov/pubmed/17610786?tool=bestpractice.com and even harmful in some instances.
Primary options
dexamethasone: 0.15 to 0.6 mg/kg orally as a single dose
moderate (stridor at rest; no agitation or lethargy)
corticosteroid + supportive care
A single dose of oral dexamethasone is given as soon as the clinical diagnosis of croup has been made. Its effect in reducing the clinical signs of croup is seen within 2 hours, with further beneficial effect noted up to 10 hours following administration.[38]Johnson DW, Jacobson S, Edney PC, et al. A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. N Engl J Med. 1998 Aug 20;339(8):498-503. http://www.ncbi.nlm.nih.gov/pubmed/9709042?tool=bestpractice.com
Traditionally, a dose of 0.6 mg/kg/dose was used for croup; however, evidence now supports the use of a smaller dose of 0.15 mg/kg/dose.[59]Aregbesola A, Tam CM, Kothari A, et al. Glucocorticoids for croup in children. Cochrane Database Syst Rev. 2023 Jan 10;1(1):CD001955. https://www.doi.org/10.1002/14651858.CD001955.pub5 http://www.ncbi.nlm.nih.gov/pubmed/36626194?tool=bestpractice.com
Nebulised budesonide is preferable in severe hypoxia, persistent vomiting, or respiratory distress preventing administration of an oral dose.
Intramuscular dexamethasone is another alternative.
Care should be taken to avoid frightening the child, as agitation may cause worsening of symptoms.[19]Johnson D, Klassen T, Kellner J. Diagnosis and management of croup: Alberta Medical Association clinical practice guidelines. Alberta: Alberta Medical Association; 2015 [internet publication]. https://www.topalbertadoctors.org/cpgs.php?sid=12&cpg_cats=35 Historically mist or humidified air have been widely employed, but there is now convincing evidence that these are ineffective[19]Johnson D, Klassen T, Kellner J. Diagnosis and management of croup: Alberta Medical Association clinical practice guidelines. Alberta: Alberta Medical Association; 2015 [internet publication]. https://www.topalbertadoctors.org/cpgs.php?sid=12&cpg_cats=35 [85]Henry R. Moist air in the treatment of laryngotracheitis. Arch Dis Child. 1983 Aug;58(8):577. https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=6614970 http://www.ncbi.nlm.nih.gov/pubmed/6614970?tool=bestpractice.com [86]Lenney W, Milner AD. Treatment of acute viral croup. Arch Dis Child. 1978 Sep;53(9):704-6. https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=718237 http://www.ncbi.nlm.nih.gov/pubmed/718237?tool=bestpractice.com [87]Bourchier D, Dawson KP, Fergusson DM. Humidification in viral croup: a controlled trial. Aust Paediatr J. 1984 Nov;20(4):289-91. http://www.ncbi.nlm.nih.gov/pubmed/6397182?tool=bestpractice.com [88]Skolnik N. Treatment of croup. A critical review. Am J Dis Child. 1989 Sep;143(9):1045-9. http://www.ncbi.nlm.nih.gov/pubmed/2672782?tool=bestpractice.com [89]Neto GM, Kentab O, Klassen TP, et al. A randomized controlled trial of mist in the acute treatment of moderate croup. Acad Emerg Med. 2002 Sep;9(9):873-9. http://www.ncbi.nlm.nih.gov/pubmed/12208675?tool=bestpractice.com [90]Lavine E, Scolnik D. Lack of efficacy of humidification in the treatment of croup. Why do physicians persist in using an unproven modality? CJEM. 2001 Jul;3(3):209-12. http://www.ncbi.nlm.nih.gov/pubmed/17610786?tool=bestpractice.com and even harmful in some instances.
Primary options
dexamethasone: 0.15 to 0.6 mg/kg orally as a single dose
OR
budesonide inhaled: 2 mg nebulised as a single dose
OR
dexamethasone: 0.6 mg/kg intramuscularly as a single dose
nebulised adrenaline (epinephrine)
Treatment recommended for ALL patients in selected patient group
In children presenting with stridor, sternal indrawing at rest, and persistent or increasing agitation, nebulised adrenaline (epinephrine) should be administered in addition to dexamethasone. It provides temporary relief of the airway obstruction while awaiting the effects of corticosteroid treatment.[68]Bjornson C, Russell K, Vandermeer B, et al. Nebulized epinephrine for croup in children. Cochrane Database Syst Rev. 2013 Oct 10;(10):CD006619.
https://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006619.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/24114291?tool=bestpractice.com
[ ]
What are the effects of nebulized epinephrine in children with croup?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.281/fullShow me the answer
The clinical effects of nebulised adrenaline (epinephrine) last on average at least 1 hour, but usually subside 2 hours after administration.[34]Westley CR, Cotton EK, Brooks JG. Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study. Am J Dis Child. 1978 May;132(5):484-7. http://www.ncbi.nlm.nih.gov/pubmed/347921?tool=bestpractice.com
The use of one dose at a time of nebulised adrenaline (epinephrine) has not been associated with any clinically significant increases in BP or heart rate, neither has it been associated with any adverse events.[74]Waisman Y, Klein BL, Boenning DA, et al. Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup). Pediatrics. 1992 Feb;89(2):302-6. http://www.ncbi.nlm.nih.gov/pubmed/1734400?tool=bestpractice.com [79]Kristjansson S, Berg-Kelly K, Winso E. Inhalation of racemic adrenaline in the treatment of mild and moderately severe croup. Clinical symptom score and oxygen saturation measurements for evaluation of treatment effects. Acta Paediatr. 1994 Nov;83(11):1156-60. http://www.ncbi.nlm.nih.gov/pubmed/7841729?tool=bestpractice.com [69]Taussig LM, Castro O, Beaudry PH, et al. Treatment of laryngotracheobronchitis (croup). Use of intermittent positive-pressure breathing and racemic epinephrine. Am J Dis Child. 1975 Jul;129(7):790-3. http://www.ncbi.nlm.nih.gov/pubmed/1096594?tool=bestpractice.com [80]Fogel JM, Berg IJ, Gerber MA, et al. Racemic epinephrine in the treatment of croup: nebulization alone versus nebulization with intermittent positive pressure breathing. J Pediatr. 1982 Dec;101(6):1028-31 http://www.ncbi.nlm.nih.gov/pubmed/6754899?tool=bestpractice.com [81]Chub-Uppakarn S, Sangsupawanich P. A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. Int J Pediatr Otorhinolaryngol. 2007 Mar;71(3):473-7. http://www.ncbi.nlm.nih.gov/pubmed/17208307?tool=bestpractice.com [82]Weber JE, Chudnofsky CR, Younger JG, et al. A randomized comparison of helium-oxygen mixture (Heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics. 2001 Jun;107(6):E96. https://pediatrics.aappublications.org/cgi/content/full/107/6/e96 http://www.ncbi.nlm.nih.gov/pubmed/11389294?tool=bestpractice.com [83]Zhang L, Sanguebsche LS. The safety of nebulization with 3 to 5 ml of adrenaline (1:1000) in children: an evidence based review. J Pediatr (Rio J). 2005 May-Jun;81(3):193-7. https://www.jped.com.br/conteudo/05-81-03-193/ing.asp http://www.ncbi.nlm.nih.gov/pubmed/15951902?tool=bestpractice.com Caution should be used with multiple doses of nebulised adrenaline (epinephrine). Careful observation is advisable if adrenaline (epinephrine) treatment is deemed necessary.
Although racemic adrenaline (epinephrine) has traditionally been used to treat children with croup, L-adrenaline (epinephrine) is as effective in moderate to severe croup.[74]Waisman Y, Klein BL, Boenning DA, et al. Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup). Pediatrics. 1992 Feb;89(2):302-6. http://www.ncbi.nlm.nih.gov/pubmed/1734400?tool=bestpractice.com In some countries, L-adrenaline (epinephrine) availability may be limited. The same dose is used regardless of weight, as the effective dose of drug delivered to the airway is regulated by individual tidal volume.[75]Janssens HM, Krijgsman A, Verbraak TF, et al. Determining factors of aerosol deposition for four pMDI-spacer combinations in an infant upper airway model. J Aerosol Med. 2004 Spring;17(1):51-61. http://www.ncbi.nlm.nih.gov/pubmed/15120013?tool=bestpractice.com [76]Fink JB. Aerosol delivery to ventilated infant and pediatric patients. Respir Care. 2004 Jun;49(6):653-65. http://www.ncbi.nlm.nih.gov/pubmed/15165300?tool=bestpractice.com [77]Schuepp KG, Straub D, Moller A, et al. Deposition of aerosols in infants and children. J Aerosol Med. 2004;17(2):153-6. http://www.ncbi.nlm.nih.gov/pubmed/15294065?tool=bestpractice.com [78]Wildhaber JH, Monkhoff M, Sennhauser FH. Dosage regimens for inhaled therapy in children should be reconsidered. J Paediatr Child Health. 2002 Apr;38(2):115-6. http://www.ncbi.nlm.nih.gov/pubmed/12030988?tool=bestpractice.com
Primary options
adrenaline inhaled: (1:1000 solution of L-adrenaline) 5 mL undiluted nebulised as a single dose
OR
adrenaline inhaled: (2.25% racemic solution) 0.5 mL diluted to 2-4 mL with normal saline nebulised as a single dose
severe (stridor at rest with agitation or lethargy)
corticosteroid + supportive care
A single dose of oral dexamethasone is given as soon as the clinical diagnosis of croup has been made. Its effect in reducing the clinical signs of croup is seen by 2 hours, with further beneficial effect noted up to 10 hours following administration.[38]Johnson DW, Jacobson S, Edney PC, et al. A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. N Engl J Med. 1998 Aug 20;339(8):498-503. http://www.ncbi.nlm.nih.gov/pubmed/9709042?tool=bestpractice.com
Traditionally, a dose of 0.6 mg/kg/dose was used for croup; however, evidence now supports the use of a smaller dose of 0.15 mg/kg/dose.[59]Aregbesola A, Tam CM, Kothari A, et al. Glucocorticoids for croup in children. Cochrane Database Syst Rev. 2023 Jan 10;1(1):CD001955. https://www.doi.org/10.1002/14651858.CD001955.pub5 http://www.ncbi.nlm.nih.gov/pubmed/36626194?tool=bestpractice.com
Nebulised budesonide is preferable in severe hypoxia, persistent vomiting or respiratory distress preventing administration of an oral dose.
Intramuscular or intravenous dexamethasone is another alternative. However, there is significant potential to increase agitation and respiratory distress when an intravenous line is inserted in a child with severe croup.
Wherever possible, the child should be kept in a calm environment with his/her caregiver. Care should be taken to minimise interventions that would increase the child’s agitation. Historically mist or humidified air have been widely employed, but there is now convincing evidence that these are ineffective[19]Johnson D, Klassen T, Kellner J. Diagnosis and management of croup: Alberta Medical Association clinical practice guidelines. Alberta: Alberta Medical Association; 2015 [internet publication]. https://www.topalbertadoctors.org/cpgs.php?sid=12&cpg_cats=35 [85]Henry R. Moist air in the treatment of laryngotracheitis. Arch Dis Child. 1983 Aug;58(8):577. https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=6614970 http://www.ncbi.nlm.nih.gov/pubmed/6614970?tool=bestpractice.com [86]Lenney W, Milner AD. Treatment of acute viral croup. Arch Dis Child. 1978 Sep;53(9):704-6. https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=718237 http://www.ncbi.nlm.nih.gov/pubmed/718237?tool=bestpractice.com [87]Bourchier D, Dawson KP, Fergusson DM. Humidification in viral croup: a controlled trial. Aust Paediatr J. 1984 Nov;20(4):289-91. http://www.ncbi.nlm.nih.gov/pubmed/6397182?tool=bestpractice.com [88]Skolnik N. Treatment of croup. A critical review. Am J Dis Child. 1989 Sep;143(9):1045-9. http://www.ncbi.nlm.nih.gov/pubmed/2672782?tool=bestpractice.com [89]Neto GM, Kentab O, Klassen TP, et al. A randomized controlled trial of mist in the acute treatment of moderate croup. Acad Emerg Med. 2002 Sep;9(9):873-9. http://www.ncbi.nlm.nih.gov/pubmed/12208675?tool=bestpractice.com [90]Lavine E, Scolnik D. Lack of efficacy of humidification in the treatment of croup. Why do physicians persist in using an unproven modality? CJEM. 2001 Jul;3(3):209-12. http://www.ncbi.nlm.nih.gov/pubmed/17610786?tool=bestpractice.com and even harmful in some instances.
Primary options
dexamethasone: 0.15 to 0.6 mg/kg orally as a single dose
OR
budesonide inhaled: 2 mg nebulised as a single dose
OR
dexamethasone: 0.6 mg/kg intramuscularly as a single dose
Secondary options
dexamethasone: 0.15 to 0.6 mg/kg intravenously as a single dose
nebulised adrenaline (epinephrine)
Treatment recommended for ALL patients in selected patient group
In children presenting with stridor, sternal/intercostal indrawing at rest, and persistent or increasing agitation, nebulised adrenaline (epinephrine) should be administered in addition to dexamethasone. It provides temporary relief of the airway obstruction while awaiting the effects of corticosteroid treatment.[68]Bjornson C, Russell K, Vandermeer B, et al. Nebulized epinephrine for croup in children. Cochrane Database Syst Rev. 2013 Oct 10;(10):CD006619.
https://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006619.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/24114291?tool=bestpractice.com
[ ]
What are the effects of nebulized epinephrine in children with croup?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.281/fullShow me the answer
The clinical effects of nebulised adrenaline (epinephrine) last on average at least 1 hour, but usually subside 2 hours after administration.[34]Westley CR, Cotton EK, Brooks JG. Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study. Am J Dis Child. 1978 May;132(5):484-7. http://www.ncbi.nlm.nih.gov/pubmed/347921?tool=bestpractice.com
The use of one dose at a time of nebulised adrenaline (epinephrine) has not been associated with any clinically significant increases in BP or heart rate; neither has it been associated with any adverse events.[74]Waisman Y, Klein BL, Boenning DA, et al. Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup). Pediatrics. 1992 Feb;89(2):302-6. http://www.ncbi.nlm.nih.gov/pubmed/1734400?tool=bestpractice.com [79]Kristjansson S, Berg-Kelly K, Winso E. Inhalation of racemic adrenaline in the treatment of mild and moderately severe croup. Clinical symptom score and oxygen saturation measurements for evaluation of treatment effects. Acta Paediatr. 1994 Nov;83(11):1156-60. http://www.ncbi.nlm.nih.gov/pubmed/7841729?tool=bestpractice.com [69]Taussig LM, Castro O, Beaudry PH, et al. Treatment of laryngotracheobronchitis (croup). Use of intermittent positive-pressure breathing and racemic epinephrine. Am J Dis Child. 1975 Jul;129(7):790-3. http://www.ncbi.nlm.nih.gov/pubmed/1096594?tool=bestpractice.com [80]Fogel JM, Berg IJ, Gerber MA, et al. Racemic epinephrine in the treatment of croup: nebulization alone versus nebulization with intermittent positive pressure breathing. J Pediatr. 1982 Dec;101(6):1028-31 http://www.ncbi.nlm.nih.gov/pubmed/6754899?tool=bestpractice.com [81]Chub-Uppakarn S, Sangsupawanich P. A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. Int J Pediatr Otorhinolaryngol. 2007 Mar;71(3):473-7. http://www.ncbi.nlm.nih.gov/pubmed/17208307?tool=bestpractice.com [82]Weber JE, Chudnofsky CR, Younger JG, et al. A randomized comparison of helium-oxygen mixture (Heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics. 2001 Jun;107(6):E96. https://pediatrics.aappublications.org/cgi/content/full/107/6/e96 http://www.ncbi.nlm.nih.gov/pubmed/11389294?tool=bestpractice.com [83]Zhang L, Sanguebsche LS. The safety of nebulization with 3 to 5 ml of adrenaline (1:1000) in children: an evidence based review. J Pediatr (Rio J). 2005 May-Jun;81(3):193-7. https://www.jped.com.br/conteudo/05-81-03-193/ing.asp http://www.ncbi.nlm.nih.gov/pubmed/15951902?tool=bestpractice.com Caution should be used with multiple doses of nebulised adrenaline (epinephrine).[84]Butte MJ, Nguyen BX, Hutchison TJ, et al. Pediatric myocardial infarction after racemic epinephrine administration. Pediatrics. 1999;104:e9. http://pediatrics.aappublications.org/cgi/content/full/104/1/e9 http://www.ncbi.nlm.nih.gov/pubmed/10390295?tool=bestpractice.com Careful observation is advisable if adrenaline (epinephrine) treatment is deemed necessary.
Although racemic adrenaline (epinephrine) has traditionally been used to treat children with croup, L-adrenaline (epinephrine) is as effective in moderate to severe croup.[74]Waisman Y, Klein BL, Boenning DA, et al. Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup). Pediatrics. 1992 Feb;89(2):302-6. http://www.ncbi.nlm.nih.gov/pubmed/1734400?tool=bestpractice.com In some countries, L-adrenaline (epinephrine) availability may be limited. The same dose is used regardless of weight, as the effective dose of drug delivered to the airway is regulated by individual tidal volume.[75]Janssens HM, Krijgsman A, Verbraak TF, et al. Determining factors of aerosol deposition for four pMDI-spacer combinations in an infant upper airway model. J Aerosol Med. 2004 Spring;17(1):51-61. http://www.ncbi.nlm.nih.gov/pubmed/15120013?tool=bestpractice.com [76]Fink JB. Aerosol delivery to ventilated infant and pediatric patients. Respir Care. 2004 Jun;49(6):653-65. http://www.ncbi.nlm.nih.gov/pubmed/15165300?tool=bestpractice.com [77]Schuepp KG, Straub D, Moller A, et al. Deposition of aerosols in infants and children. J Aerosol Med. 2004;17(2):153-6. http://www.ncbi.nlm.nih.gov/pubmed/15294065?tool=bestpractice.com [78]Wildhaber JH, Monkhoff M, Sennhauser FH. Dosage regimens for inhaled therapy in children should be reconsidered. J Paediatr Child Health. 2002 Apr;38(2):115-6. http://www.ncbi.nlm.nih.gov/pubmed/12030988?tool=bestpractice.com
Primary options
adrenaline inhaled: (1:1000 solution of L-adrenaline) 5 mL undiluted nebulised as a single dose
OR
adrenaline inhaled: (2.25% racemic solution) 0.5 mL diluted to 2-4mL with normal saline nebulised as a single dose
supplemental oxygen
Treatment recommended for ALL patients in selected patient group
Humidified oxygen is given to children demonstrating significant signs and symptoms of respiratory distress, preferably as blow-by oxygen via tubing held a few centimetres from the child's nose and mouth.
In the event that oxygenation is insufficient using this method, 100% oxygen via a non-re-breather mask is administered. However, the application of the mask to the face carries the potential for increasing agitation and preparations (experienced personnel, intubation equipment, medications) should be made to secure the airway if the clinical situation worsens to impending respiratory failure.
Oxygen saturation monitoring should occur, providing this does not increase the child's level of agitation.
Primary options
oxygen: 8 to 10 L/min blow-by
Secondary options
oxygen: 100% by non-re-breather mask
intubation
Additional treatment recommended for SOME patients in selected patient group
Indicated in children progressing to asynchronous chest wall and abdominal movement, fatigue, and signs of hypoxia (pallor or cyanosis) and hypercapnia (decreased level of consciousness secondary to rising PaCO₂).
Becoming increasingly uncommon (in only 1% to 3% of children admitted with croup) and performed as rapid sequence induction in a controlled setting with experienced personnel and equipment.[48]Sofer S, Dagan R, Tal A. The need for intubation in serious upper respiratory tract infection in pediatric patients (a retrospective study). Infection. 1991 May-Jun;19(3):131-4. http://www.ncbi.nlm.nih.gov/pubmed/1889864?tool=bestpractice.com [49]Sendi K, Crysdale WS, Yoo J. Tracheitis: outcome of 1,700 cases presenting to the emergency department during two years. J Otolaryngol. 1992 Feb;21(1):20-4. http://www.ncbi.nlm.nih.gov/pubmed/1564745?tool=bestpractice.com [50]Tan AK, Manoukian JJ. Hospitalized croup (bacterial and viral): the role of rigid endoscopy. J Otolaryngol. 1992 Feb;21(1):48-53. http://www.ncbi.nlm.nih.gov/pubmed/1564750?tool=bestpractice.com [51]Dawson KP, Mogridge N, Downward G. Severe acute laryngotracheitis in Christchurch 1980-90. N Z Med J. 1991 Sep 11;104(919):374-5. http://www.ncbi.nlm.nih.gov/pubmed/1923075?tool=bestpractice.com
Advisable to have a selection of endotracheal tubes of smaller sizes at hand, as subglottic oedema may cause difficulty when intubating with a standard sized endotracheal tube.
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer